Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus [1]

Rheumatology

Volumn 47, Issue 1, 2008, Pages 102-103

  Sánchez, Elena ^a,b   Sabio, J M ^a   Jimenez alonso J ^a   Callejas, J L ^c   Camps, M ^d   De Ramon E ^d   Garcia Portales R ^e   de Haro, M ^e   Ortego Centeno, N ^c   Lopez Nevot M A ^b   Martin J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AUTOIMMUNITY; CHROMOSOME 16P; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EXON; FALSE NEGATIVE RESULT; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; SPAIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANS-ACTIVATORS;

EID: 37349070816     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem242     Document Type: Letter

References (10)

1. Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000;66:547-56.
2. Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 2001;19:331-73.
3. Swanberg M, Lidman O, Padyukov L et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005:37:486-94.
4. Akkad DA, Jagiello P, Szyld P et al. Promoter poymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int J Immunogenet 2006;33:59-61.
5. Orozco G, Robledo G, Lings, Reddy MV et al. Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations. Rheumatology 2006;45:1442-4.
6. Martinez A, Sanchez-Lopez M, Varade J et al. Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007;66:325-9.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus arythematosus. Arthritis Rheum 1997;40; 1725.
8. Sanchez E, Gomez LM, Lopez-Nevat MA et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006;7:433-6.
9. Eyre S, Bowes J, Spreckley K et al. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 2006;54:3417-22.
10. Koizumi K, Okamoto H, Iikuni N et al. Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transectivator (CIITA) in systemic lupus erythematosus. Ann Rheum Dis 2005;64:947-50.